Collaboration between XtalPi and ABIC: Advancing Scientific Research and Commercialization

In an exciting partnership, XtalPi Inc. and the Advanced Biomedical Instrumentation Centre (ABIC) at the University of Hong Kong (HKU) have joined forces to drive scientific research and commercialization efforts. This collaboration aims to leverage ABIC's cutting-edge technology and XtalPi's expertise in physics-based computation, artificial intelligence (AI), and robotics to revolutionize the biotech and life science industries. Join us as we explore the details of this collaboration and its potential impact on healthcare in Asia and beyond.

Collaboration for Scientific Research and Commercialization

Discover the partnership between XtalPi and ABIC to advance scientific research and commercialize deep tech

Collaboration between XtalPi and ABIC: Advancing Scientific Research and Commercialization - 574839476

XtalPi Inc. and the Advanced Biomedical Instrumentation Centre (ABIC) at the University of Hong Kong (HKU) have signed a memorandum of understanding (MoU) to collaborate on scientific research and commercialization of deep tech developed by ABIC researchers in Hong Kong and globally. This collaboration aims to leverage ABIC's cutting-edge technology and XtalPi's expertise in physics-based computation, artificial intelligence (AI), and robotics to revolutionize the biotech and life science industries.

By joining forces, XtalPi and ABIC aim to bridge the gap between academia and industry, bringing innovative technologies to the market. XtalPi will assess the commercial potential of ABIC's technology and intellectual property portfolio, while ABIC will benefit from XtalPi's global expertise in commercialization-driven groups. Together, they strive to develop affordable next-generation diagnostic and therapeutic technologies that will have a significant impact on healthcare in Asia and beyond.

Expertise in Therapeutic Discovery and AI

Explore XtalPi's expertise in therapeutic discovery, development, engineering, and AI

XtalPi is renowned for its integration of physics-based computation, artificial intelligence (AI), and robotics to advance the discovery of medicines and materials. With a global team of experts, XtalPi is at the forefront of developing innovative solutions for the biotech and life science industries.

Through this collaboration, XtalPi will lead the commercialization efforts of selected ABIC technologies, combining their expertise in therapeutic discovery and AI with ABIC's cutting-edge research. This collaboration will facilitate knowledge exchange between XtalPi's team and ABIC researchers, driving the translation of scientific concepts into practical solutions.

Driving Innovation in the Biotech Industry

Learn how XtalPi and ABIC are driving innovation in the biotech industry

This collaboration between XtalPi and ABIC aims to foster collaboration between research organizations and commercialization-driven groups, bringing together engineers, scientists, and clinicians to develop affordable next-generation diagnostic and therapeutic technologies.

By leveraging XtalPi's global expertise and ABIC's impressive portfolio of technologies, this partnership seeks to make a significant impact on healthcare in Asia and beyond. The biotech industry in Hong Kong and the Greater Bay Area will benefit from the translation of scientific research into practical solutions, driving innovation and improving patient outcomes.